Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for: Laboratory

HEALTH-CORONAVIRUS/THAILAND-VACCINE
RTS38VO5
May 25, 2020
A researcher works inside a laboratory of the Biological Institute Department of Medical Science Ministry...
Bangkok, Thailand
The coronavirus disease (COVID-19) vaccine test in Thailand
A researcher works inside a laboratory of the Biological Institute Department of Medical Science Ministry of Public Health during a study on the coronavirus disease (COVID-19) growth in animal cells in Bangkok, Thailand, May 25, 2020. REUTERS/Athit Perawongmetha
HEALTH-CORONAVIRUS/THAILAND-VACCINE
RTS38VO0
May 25, 2020
Vero's cells are seen inside a laboratory of the Biological Institute Department of Medical Science Ministry...
Bangkok, Thailand
The coronavirus disease (COVID-19) vaccine test in Thailand
Vero's cells are seen inside a laboratory of the Biological Institute Department of Medical Science Ministry of Public Health during a study on the coronavirus disease (COVID-19) growth in animal cells in Bangkok, Thailand, May 25, 2020. REUTERS/Athit Perawongmetha
HEALTH-CORONAVIRUS/THAILAND-VACCINE
RTS38VNY
May 25, 2020
A researcher works inside a laboratory of Chulalongkorn University during the development of an mRNA...
Bangkok, Thailand
The coronavirus disease (COVID-19) vaccine test in Thailand
A researcher works inside a laboratory of Chulalongkorn University during the development of an mRNA type vaccine candidate for the coronavirus disease (COVID-19) in Bangkok, Thailand, May 25, 2020. REUTERS/Athit Perawongmetha
HEALTH-CORONAVIRUS/THAILAND-VACCINE
RTS38VN7
May 25, 2020
A researcher works inside a laboratory of Chulalongkorn University during the development of an mRNA...
Bangkok, Thailand
The coronavirus disease (COVID-19) vaccine test in Thailand
A researcher works inside a laboratory of Chulalongkorn University during the development of an mRNA type vaccine candidate for the coronavirus disease (COVID-19) in Bangkok, Thailand, May 25, 2020. REUTERS/Athit Perawongmetha
HEALTH-CORONAVIRUS/THAILAND-VACCINE
RTS38VL8
May 25, 2020
Vero's cells are seen through a microscope inside a laboratory of the Biological Institute Department...
Bangkok, Thailand
The coronavirus disease (COVID-19) vaccine test in Thailand
Vero's cells are seen through a microscope inside a laboratory of the Biological Institute Department of Medical Science Ministry of Public Health during a study on the coronavirus disease (COVID-19) growth in animal cells in Bangkok, Thailand, May 25, 2020. REUTERS/Athit Perawongmetha
HEALTH-CORONAVIRUS/THAILAND-VACCINE
RTS38VL6
May 25, 2020
A researcher works inside a laboratory of Chulalongkorn University during the development of an mRNA...
Bangkok, Thailand
The coronavirus disease (COVID-19) vaccine test in Thailand
A researcher works inside a laboratory of Chulalongkorn University during the development of an mRNA type vaccine candidate for the coronavirus disease (COVID-19) in Bangkok, Thailand, May 25, 2020. REUTERS/Athit Perawongmetha
HEALTH-CORONAVIRUS/THAILAND-VACCINE
RTS38VL5
May 25, 2020
A researcher works inside a laboratory of Chulalongkorn University during the development of an mRNA...
Bangkok, Thailand
The coronavirus disease (COVID-19) vaccine test in Thailand
A researcher works inside a laboratory of Chulalongkorn University during the development of an mRNA type vaccine candidate for the coronavirus disease (COVID-19) in Bangkok, Thailand, May 25, 2020. REUTERS/Athit Perawongmetha
HEALTH-CORONAVIRUS/USA-SORRENTO
RTX7K5FH
May 22, 2020
A sign reading "Play Like A Champion Today" is seen inside a laboratory at Sorrento Therapeutics, where...
San Diego, UNITED STATES
Sorrento Therapeutics in San Diego works on developing an antibody
A sign reading "Play Like A Champion Today" is seen inside a laboratory at Sorrento Therapeutics, where efforts are underway to develop an antibody, STI-1499, to help in prevention of the coronavirus disease (COVID-19) in San Diego, California, U.S., May 22, 2020. REUTERS/Bing Guan
HEALTH-CORONAVIRUS/USA-SORRENTO
RTX7K5FG
May 22, 2020
Laboratory equipment is seen at Sorrento Therapeutics where efforts are underway to develop an antibody,...
San Diego, UNITED STATES
Sorrento Therapeutics in San Diego works on developing an antibody
Laboratory equipment is seen at Sorrento Therapeutics where efforts are underway to develop an antibody, STI-1499, to help in prevention of the coronavirus disease (COVID-19) in San Diego, California, U.S., May 22, 2020. REUTERS/Bing Guan
HEALTH-CORONAVIRUS/USA-SORRENTO
RTX7K5DW
May 22, 2020
A scientist holds up sample vials inside a laboratory at Sorrento Therapeutics where efforts are underway...
San Diego, UNITED STATES
Sorrento Therapeutics in San Diego works on developing an antibody
A scientist holds up sample vials inside a laboratory at Sorrento Therapeutics where efforts are underway to develop an antibody, STI-1499, to help in prevention of the coronavirus disease (COVID-19) in San Diego, California, U.S., May 22, 2020. REUTERS/Bing Guan
HEALTH-CORONAVIRUS/USA-SORRENTO
RTX7K5DX
May 22, 2020
An Attune NxT Flow Cytometer is seen inside a laboratory at Sorrento Therapeutics where efforts are underway...
San Diego, UNITED STATES
Sorrento Therapeutics in San Diego works on developing an antibody
An Attune NxT Flow Cytometer is seen inside a laboratory at Sorrento Therapeutics where efforts are underway to develop an antibody, STI-1499, to help in prevention of the coronavirus disease (COVID-19) in San Diego, California, U.S., May 22, 2020. REUTERS/Bing Guan
HEALTH-CORONAVIRUS/USA-SORRENTO
RTX7K5DR
May 22, 2020
A scientist loads samples into a laboratory freezer at Sorrento Therapeutics where efforts are underway...
San Diego, UNITED STATES
Sorrento Therapeutics in San Diego works on developing an antibody
A scientist loads samples into a laboratory freezer at Sorrento Therapeutics where efforts are underway to develop an antibody, STI-1499, to help in prevention of the coronavirus disease (COVID-19) in San Diego, California, U.S., May 22, 2020. REUTERS/Bing Guan
HEALTH-CORONAVIRUS/USA-SORRENTO
RTX7K5DK
May 22, 2020
Sample vials are seen inside a laboratory at Sorrento Therapeutics where efforts are underway to develop...
San Diego, UNITED STATES
Sorrento Therapeutics in San Diego works on developing an antibody
Sample vials are seen inside a laboratory at Sorrento Therapeutics where efforts are underway to develop an antibody, STI-1499, to help in prevention of the coronavirus disease (COVID-19) in San Diego, California, U.S., May 22, 2020. REUTERS/Bing Guan
HEALTH-CORONAVIRUS/USA-SORRENTO
RTX7K5D4
May 22, 2020
Pipettes and sample vials are seen inside a laboratory at Sorrento Therapeutics where efforts are underway...
San Diego, UNITED STATES
Sorrento Therapeutics in San Diego works on developing an antibody
Pipettes and sample vials are seen inside a laboratory at Sorrento Therapeutics where efforts are underway to develop an antibody, STI-1499, to help in prevention of the coronavirus disease (COVID-19) in San Diego, California, U.S., May 22, 2020. REUTERS/Bing Guan
HEALTH-CORONAVIRUS/USA-SORRENTO
RTX7K5D3
May 22, 2020
Associate director Dr. Hua Wang works in a laboratory at Sorrento Therapeutics, where efforts are underway...
San Diego, UNITED STATES
Sorrento Therapeutics in San Diego works on developing an antibody
Associate director Dr. Hua Wang works in a laboratory at Sorrento Therapeutics, where efforts are underway to develop an antibody, STI-1499, to help in prevention of the coronavirus disease (COVID-19) in San Diego, California, U.S., May 22, 2020. REUTERS/Bing Guan
HEALTH-CORONAVIRUS/USA-SORRENTO
RTX7K5CY
May 22, 2020
Research associate Kenneth Roy Rienecker III works in a laboratory at Sorrento Therapeutics where efforts...
San Diego, UNITED STATES
Sorrento Therapeutics in San Diego works on developing an antibody
Research associate Kenneth Roy Rienecker III works in a laboratory at Sorrento Therapeutics where efforts are underway to develop an antibody, STI-1499, to help in prevention of the coronavirus disease (COVID-19) in San Diego, California, U.S., May 22, 2020. REUTERS/Bing Guan
HEALTH-CORONAVIRUS/USA-SORRENTO
RTX7K5CR
May 22, 2020
Sorrento Therapeutics CEO Dr. Henry Ji takes a phone call inside one of Sorrento?s laboratories, where...
San Diego, UNITED STATES
Sorrento Therapeutics in San Diego works on developing an antibody
Sorrento Therapeutics CEO Dr. Henry Ji takes a phone call inside one of Sorrento?s laboratories, where efforts are underway to develop an antibody, STI-1499, to help in prevention of the coronavirus disease (COVID-19) in San Diego, California, U.S., May 22, 2020. REUTERS/Bing Guan
HEALTH-CORONAVIRUS/USA-SORRENTO
RTX7K5CI
May 22, 2020
A laboratory bench covered in equipment is seen at Sorrento Therapeutics where efforts are underway to...
San Diego, UNITED STATES
Sorrento Therapeutics in San Diego works on developing an antibody
A laboratory bench covered in equipment is seen at Sorrento Therapeutics where efforts are underway to develop an antibody, STI-1499, to help in prevention of the coronavirus disease (COVID-19) in San Diego, California, U.S., May 22, 2020. REUTERS/Bing Guan
HEALTH-CORONAVIRUS/USA-SORRENTO
RTX7K5CB
May 22, 2020
Sample vials are seen inside a laboratory at Sorrento Therapeutics where efforts are underway to develop...
San Diego, UNITED STATES
Sorrento Therapeutics in San Diego works on developing an antibody
Sample vials are seen inside a laboratory at Sorrento Therapeutics where efforts are underway to develop an antibody, STI-1499, to help in prevention of the coronavirus disease (COVID-19) in San Diego, California, U.S., May 22, 2020. REUTERS/Bing Guan
HEALTH-CORONAVIRUS/USA-SORRENTO
RTX7K5BZ
May 22, 2020
Sample vials are seen inside a laboratory refrigerator at Sorrento Therapeutics, where efforts are underway...
San Diego, UNITED STATES
Sorrento Therapeutics in San Diego works on developing an antibody
Sample vials are seen inside a laboratory refrigerator at Sorrento Therapeutics, where efforts are underway to develop an antibody, STI-1499, to help in prevention of the coronavirus disease (COVID-19) in San Diego, California, U.S., May 22, 2020. REUTERS/Bing Guan
HEALTH-CORONAVIRUS/USA-SORRENTO
RTX7K5BO
May 22, 2020
Pipettes are seen in a laboratory at Sorrento Therapeutics where efforts are underway to develop an antibody,...
San Diego, UNITED STATES
Sorrento Therapeutics in San Diego works on developing an antibody
Pipettes are seen in a laboratory at Sorrento Therapeutics where efforts are underway to develop an antibody, STI-1499, to help in prevention of the coronavirus disease (COVID-19) in San Diego, California, U.S., May 22, 2020. REUTERS/Bing Guan
HEALTH-CORONAVIRUS/INDIA-SERUM
RTX7K3J7
May 22, 2020
A research scientist works inside a laboratory of India's Serum Institute, the world's largest maker...
Pune, India
Outbreak of the coronavirus disease (COVID-19) in Pune
A research scientist works inside a laboratory of India's Serum Institute, the world's largest maker of vaccines, which is working on vaccines against the coronavirus disease (COVID-19) in Pune, India, May 18, 2020. Picture taken May 18, 2020. REUTERS/Euan Rocha
HEALTH-CORONAVIRUS/INDIA-SERUM
RTX7K3J8
May 22, 2020
A man walks past a signpost of India's Serum Institute, the world's largest maker of vaccines, which...
Pune, India
Outbreak of the coronavirus disease (COVID-19) in Pune
A man walks past a signpost of India's Serum Institute, the world's largest maker of vaccines, which is developing a vaccine against the coronavirus disease (COVID-19) at its laboratory in Pune, India, May 18, 2020. Picture taken May 18, 2020. REUTERS/Euan Rocha
HEALTH-CORONAVIRUS/INDIA-SERUM
RTX7K3J6
May 22, 2020
A research scientist works inside a laboratory of India's Serum Institute, the world's largest maker...
Pune, India
Outbreak of the coronavirus disease (COVID-19) in Pune
A research scientist works inside a laboratory of India's Serum Institute, the world's largest maker of vaccines, which is working on vaccines against the coronavirus disease (COVID-19) in Pune, India, May 18, 2020. Picture taken May 18, 2020. REUTERS/Euan Rocha
HEALTH-CORONAVIRUS/INDIA-SERUM
RTX7K3J5
May 22, 2020
A research scientist works inside a laboratory of India's Serum Institute, the world's largest maker...
Pune, India
Outbreak of the coronavirus disease (COVID-19) in Pune
A research scientist works inside a laboratory of India's Serum Institute, the world's largest maker of vaccines, which is working on vaccines against the coronavirus disease (COVID-19) in Pune, India, May 18, 2020. Picture taken May 18, 2020. REUTERS/Euan Rocha
HEALTH-CORONAVIRUS/ISRAEL-MASKS
RTX7JUVL
May 21, 2020
Packaging of Israel's Sonovia Ltd's washable and reusable antiviral masks, which the company says can...
Ramat Gan, Israel
Packaging of Israel's Sonovia Ltd's washable and reusable antiviral masks is displayed in Ramat Gan
Packaging of Israel's Sonovia Ltd's washable and reusable antiviral masks, which the company says can help stop the spread of the coronavirus disease (COVID-19), is displayed along with the masks at the company laboratory, in Ramat Gan, Israel May 17, 2020. Picture taken May 17, 2020. REUTERS/Amir Cohen
HEALTH-CORONAVIRUS/ISRAEL-MASKS
RTX7JUVG
May 21, 2020
Employees of Israel's Sonovia Ltd, makers of washable and reusable antiviral masks, which the company...
Ramat Gan, Israel
Employees of Israel's Sonovia Ltd, makers of washable and reusable antiviral masks work at their laboratory...
Employees of Israel's Sonovia Ltd, makers of washable and reusable antiviral masks, which the company says can help stop the spread of the coronavirus disease (COVID-19), work at their laboratory in Ramat Gan, Israel May 17, 2020. Picture taken May 17, 2020. REUTERS/Amir Cohen
HEALTH-CORONAVIRUS/ISRAEL-MASKS
RTX7JUVE
May 21, 2020
Employees of Israel's Sonovia Ltd, makers of washable and reusable antiviral masks, which the company...
Ramat Gan, Israel
Employees of Israel's Sonovia Ltd, makers of washable and reusable antiviral masks work at their laboratory...
Employees of Israel's Sonovia Ltd, makers of washable and reusable antiviral masks, which the company says can help stop the spread of the coronavirus disease (COVID-19), work at their laboratory in Ramat Gan, Israel May 17, 2020. Picture taken May 17, 2020. REUTERS/Amir Cohen
HEALTH-CORONAVIRUS/ISRAEL-MASKS
RTX7JUV0
May 21, 2020
Employees of Israel's Sonovia Ltd, makers of washable and reusable antiviral masks, which the company...
Ramat Gan, Israel
Employees of Israel's Sonovia Ltd, makers of washable and reusable antiviral masks work at their laboratory...
Employees of Israel's Sonovia Ltd, makers of washable and reusable antiviral masks, which the company says can help stop the spread of the coronavirus disease (COVID-19), work at their laboratory in Ramat Gan, Israel May 17, 2020. Picture taken May 17, 2020. REUTERS/Amir Cohen
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX7JRMR
May 20, 2020
A scientist examines COVID-19 infected cells during research for a vaccine against the coronavirus disease...
Saint Petersburg, Russia
A scientist examines COVID-19 infected cells during research for a vaccine against the coronavirus disease...
A scientist examines COVID-19 infected cells during research for a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in Saint Petersburg, Russia May 20, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX7JRFY
May 20, 2020
A scientist examines COVID-19 infected cells under a microscope during research for a vaccine against...
Saint Petersburg, Russia
A scientist examines COVID-19 infected cells during research for a vaccine against the coronavirus disease...
A scientist examines COVID-19 infected cells under a microscope during research for a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in Saint Petersburg, Russia May 20, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX7JRFW
May 20, 2020
A scientist examines COVID-19 infected cells under a microscope during research for a vaccine against...
Saint Petersburg, Russia
A scientist examines COVID-19 infected cells under a microscope during research for a vaccine against...
A scientist examines COVID-19 infected cells under a microscope during research for a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in Saint Petersburg, Russia May 20, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/RUSSIA-VACCINE
RTX7JRFI
May 20, 2020
A scientist examines COVID-19 infected cells under a microscope during research for a vaccine against...
Saint Petersburg, Russia
A scientist examines COVID-19 infected cells under a microscope during research for a vaccine against...
A scientist examines COVID-19 infected cells under a microscope during research for a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in Saint Petersburg, Russia May 20, 2020. REUTERS/Anton Vaganov
HEALTH-CORONAVIRUS/NETHERLANDS-PLASMA
RTX7JN34
May 19, 2020
Senior technician, Benoit Samson-Couterie, conducts research into antibodies against the coronavirus...
Amsterdam, Netherlands
Coronavirus disease (COVID-19) research in Amsterdam
Senior technician, Benoit Samson-Couterie, conducts research into antibodies against the coronavirus disease (COVID-19) in a laboratory at Sanquin blood bank in Amsterdam, Netherlands, May 19, 2020. REUTERS/Piroschka van de Wouw
HEALTH-CORONAVIRUS/NETHERLANDS-PLASMA
RTX7JN30
May 19, 2020
Senior technician, Benoit Samson-Couterie, conducts research into antibodies against the coronavirus...
Amsterdam, Netherlands
Coronavirus disease (COVID-19) research in Amsterdam
Senior technician, Benoit Samson-Couterie, conducts research into antibodies against the coronavirus disease (COVID-19) in a laboratory at Sanquin blood bank in Amsterdam, Netherlands, May 19, 2020. REUTERS/Piroschka van de Wouw
HEALTH-CORONAVIRUS/NETHERLANDS-PLASMA
RTX7JN1C
May 19, 2020
Samples are displayed as senior technician, Benoit Samson-Couterie, conducts research into antibodies...
Amsterdam, Netherlands
Coronavirus disease (COVID-19) research in Amsterdam
Samples are displayed as senior technician, Benoit Samson-Couterie, conducts research into antibodies against the coronavirus disease (COVID-19) in a laboratory at Sanquin blood bank in Amsterdam, Netherlands, May 19, 2020. REUTERS/Piroschka van de Wouw
HEALTH-CORONAVIRUS/NETHERLANDS-PLASMA
RTX7JMZ7
May 19, 2020
Senior technician, Benoit Samson-Couterie, conducts research into antibodies against the coronavirus...
Amsterdam, Netherlands
Coronavirus disease (COVID-19) research in Amsterdam
Senior technician, Benoit Samson-Couterie, conducts research into antibodies against the coronavirus disease (COVID-19) in a laboratory at Sanquin blood bank in Amsterdam, Netherlands, May 19, 2020. REUTERS/Piroschka van de Wouw
HEALTH-CORONAVIRUS/NETHERLANDS-PLASMA
RTX7JMZ6
May 19, 2020
Senior technician, Benoit Samson-Couterie, conducts research into antibodies against the coronavirus...
Amsterdam, Netherlands
Coronavirus disease (COVID-19) research in Amsterdam
Senior technician, Benoit Samson-Couterie, conducts research into antibodies against the coronavirus disease (COVID-19) in a laboratory at Sanquin blood bank in Amsterdam, Netherlands, May 19, 2020. REUTERS/Piroschka van de Wouw
HEALTH-CORONAVIRUS/NETHERLANDS-PLASMA
RTX7JMYS
May 19, 2020
Senior technician, Benoit Samson-Couterie, conducts research into antibodies against the coronavirus...
Amsterdam, Netherlands
Coronavirus disease (COVID-19) research in Amsterdam
Senior technician, Benoit Samson-Couterie, conducts research into antibodies against the coronavirus disease (COVID-19) in a laboratory at Sanquin blood bank in Amsterdam, Netherlands, May 19, 2020. REUTERS/Piroschka van de Wouw
HEALTH-CORONAVIRUS/SAFRICA-VACCINE
RTX7JJHW
May 19, 2020
A medical researcher studying the BCG vaccine for tuberculosis examines test samples in a laboratory...
Cape Town, South Africa
Researchers studying the BCG vaccine for tuberculosis test samples in a laboratory in Cape Town
A medical researcher studying the BCG vaccine for tuberculosis examines test samples in a laboratory run by South African biotech company TASK in Cape Town, South Africa, May 11, 2020. Picture taken May 11, 2020. REUTERS/Mike Hutchings
HEALTH-CORONAVIRUS/SAFRICA-VACCINE
RTX7JJHX
May 19, 2020
A medical researcher studying the BCG vaccine for tuberculosis examines test samples in a laboratory...
Cape Town, South Africa
Researchers studying the BCG vaccine for tuberculosis test samples in a laboratory in Cape Town
A medical researcher studying the BCG vaccine for tuberculosis examines test samples in a laboratory run by South African biotech company TASK in Cape Town, South Africa, May 11, 2020. Picture taken May 11, 2020. REUTERS/Mike Hutchings
HEALTH-CORONAVIRUS/SAFRICA-VACCINE
RTX7JJHV
May 19, 2020
Researchers studying the BCG vaccine for tuberculosis test samples in a laboratory run by South African...
Cape Town, South Africa
Researchers studying the BCG vaccine for tuberculosis test samples in a laboratory in Cape Town
Researchers studying the BCG vaccine for tuberculosis test samples in a laboratory run by South African biotech company TASK in Cape Town, South Africa, May 11, 2020. Picture taken May 11, 2020. REUTERS/Mike Hutchings
HEALTH-CORONAVIRUS/FRANCE-TESTS
RTS38S02
May 18, 2020
Coronavirus serology tests are seen at the Biogroup-LCD laboratory's technical platform in Levallois-Perret,...
LEVALLOIS-PERRET, France
Outbreak of the coronavirus disease (COVID-19) in Paris
Coronavirus serology tests are seen at the Biogroup-LCD laboratory's technical platform in Levallois-Perret, near Paris after France began a gradual end to a nationwide lockdown due to the coronavirus disease (COVID-19) outbreak, France, May 18, 2020. REUTERS/Benoit Tessier
HEALTH-CORONAVIRUS/FRANCE-TESTS
RTS38RZR
May 18, 2020
A staff member works on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform...
LEVALLOIS-PERRET, France
Outbreak of the coronavirus disease (COVID-19) in Paris
A staff member works on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform in Levallois-Perret, near Paris after France began a gradual end to a nationwide lockdown due to the coronavirus disease (COVID-19) outbreak, France, May 18, 2020. REUTERS/Benoit Tessier
HEALTH-CORONAVIRUS/FRANCE-TESTS
RTS38RZH
May 18, 2020
A staff member works on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform...
LEVALLOIS-PERRET, France
Outbreak of the coronavirus disease (COVID-19) in Paris
A staff member works on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform in Levallois-Perret, near Paris after France began a gradual end to a nationwide lockdown due to the coronavirus disease (COVID-19) outbreak, France, May 18, 2020. REUTERS/Benoit Tessier
HEALTH-CORONAVIRUS/FRANCE-TESTS
RTS38RZF
May 18, 2020
A staff member works on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform...
LEVALLOIS-PERRET, France
Outbreak of the coronavirus disease (COVID-19) in Paris
A staff member works on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform in Levallois-Perret, near Paris after France began a gradual end to a nationwide lockdown due to the coronavirus disease (COVID-19) outbreak, France, May 18, 2020. REUTERS/Benoit Tessier
HEALTH-CORONAVIRUS/FRANCE-TESTS
RTS38RZA
May 18, 2020
Staff members work on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform...
LEVALLOIS-PERRET, France
Outbreak of the coronavirus disease (COVID-19) in Paris
Staff members work on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform in Levallois-Perret, near Paris after France began a gradual end to a nationwide lockdown due to the coronavirus disease (COVID-19) outbreak, France, May 18, 2020. REUTERS/Benoit Tessier
HEALTH-CORONAVIRUS/FRANCE-TESTS
RTS38RYV
May 18, 2020
Staff members work on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform...
LEVALLOIS-PERRET, France
Outbreak of the coronavirus disease (COVID-19) in Paris
Staff members work on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform in Levallois-Perret, near Paris after France began a gradual end to a nationwide lockdown due to the coronavirus disease (COVID-19) outbreak, France, May 18, 2020. REUTERS/Benoit Tessier
HEALTH-CORONAVIRUS/FRANCE-TESTS
RTS38RYL
May 18, 2020
A staff member works on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform...
LEVALLOIS-PERRET, France
Outbreak of the coronavirus disease (COVID-19) in Paris
A staff member works on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform in Levallois-Perret, near Paris after France began a gradual end to a nationwide lockdown due to the coronavirus disease (COVID-19) outbreak, France, May 18, 2020. REUTERS/Benoit Tessier
HEALTH-CORONAVIRUS/FRANCE-TESTS
RTS38RYJ
May 18, 2020
A staff member works on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform...
LEVALLOIS-PERRET, France
Outbreak of the coronavirus disease (COVID-19) in Paris
A staff member works on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform in Levallois-Perret, near Paris after France began a gradual end to a nationwide lockdown due to the coronavirus disease (COVID-19) outbreak, France, May 18, 2020. REUTERS/Benoit Tessier
HEALTH-CORONAVIRUS/FRANCE-TESTS
RTS38RYE
May 18, 2020
A staff member works on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform...
LEVALLOIS-PERRET, France
Outbreak of the coronavirus disease (COVID-19) in Paris
A staff member works on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform in Levallois-Perret, near Paris after France began a gradual end to a nationwide lockdown due to the coronavirus disease (COVID-19) outbreak, France, May 18, 2020. REUTERS/Benoit Tessier
HEALTH-CORONAVIRUS/FRANCE-TESTS
RTS38RYD
May 18, 2020
A staff member works on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform...
LEVALLOIS-PERRET, France
Outbreak of the coronavirus disease (COVID-19) in Paris
A staff member works on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform in Levallois-Perret, near Paris after France began a gradual end to a nationwide lockdown due to the coronavirus disease (COVID-19) outbreak, France, May 18, 2020. REUTERS/Benoit Tessier
HEALTH-CORONAVIRUS/FRANCE-TESTS
RTS38RY8
May 18, 2020
Staff members work on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform...
LEVALLOIS-PERRET, France
Outbreak of the coronavirus disease (COVID-19) in Paris
Staff members work on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform in Levallois-Perret, near Paris after France began a gradual end to a nationwide lockdown due to the coronavirus disease (COVID-19) outbreak, France, May 18, 2020. REUTERS/Benoit Tessier
HEALTH-CORONAVIRUS/FRANCE-TESTS
RTS38RY0
May 18, 2020
A staff member works on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform...
LEVALLOIS-PERRET, France
Outbreak of the coronavirus disease (COVID-19) in Paris
A staff member works on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform in Levallois-Perret, near Paris after France began a gradual end to a nationwide lockdown due to the coronavirus disease (COVID-19) outbreak, France, May 18, 2020. REUTERS/Benoit Tessier
HEALTH-CORONAVIRUS/FRANCE-TESTS
RTS38RXV
May 18, 2020
A staff member works on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform...
LEVALLOIS-PERRET, France
Outbreak of the coronavirus disease (COVID-19) in Paris
A staff member works on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform in Levallois-Perret, near Paris after France began a gradual end to a nationwide lockdown due to the coronavirus disease (COVID-19) outbreak, France, May 18, 2020. REUTERS/Benoit Tessier
HEALTH-CORONAVIRUS/FRANCE-TESTS
RTS38RXP
May 18, 2020
A staff member works on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform...
LEVALLOIS-PERRET, France
Outbreak of the coronavirus disease (COVID-19) in Paris
A staff member works on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform in Levallois-Perret, near Paris after France began a gradual end to a nationwide lockdown due to the coronavirus disease (COVID-19) outbreak, France, May 18, 2020. REUTERS/Benoit Tessier
HEALTH-CORONAVIRUS/FRANCE-TESTS
RTS38RWY
May 18, 2020
Staff members work on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform...
LEVALLOIS-PERRET, France
Outbreak of the coronavirus disease (COVID-19) in Paris
Staff members work on coronavirus serology tests at the Biogroup-LCD laboratory's technical platform in Levallois-Perret, near Paris after France began a gradual end to a nationwide lockdown due to the coronavirus disease (COVID-19) outbreak, France, May 18, 2020. REUTERS/Benoit Tessier
HEALTH-CORONAVIRUS/FRANCE-TESTS
RTS38RWJ
May 18, 2020
Blood samples for COVID-19 serological tests are seen at a laboratory in Neuilly-sur-Seine near Paris...
Neuilly-Sur-Seine, France
Outbreak of the coronavirus disease (COVID-19) in Paris
Blood samples for COVID-19 serological tests are seen at a laboratory in Neuilly-sur-Seine near Paris after France began a gradual end to a nationwide lockdown due to the coronavirus disease (COVID-19) outbreak, France, May 18, 2020. REUTERS/Benoit Tessier
HEALTH-CORONAVIRUS/FRANCE-TESTS
RTS38RWE
May 18, 2020
Blood samples for COVID-19 serological tests are seen at a laboratory in Neuilly-sur-Seine near Paris...
Neuilly-Sur-Seine, France
Outbreak of the coronavirus disease (COVID-19) in Paris
Blood samples for COVID-19 serological tests are seen at a laboratory in Neuilly-sur-Seine near Paris after France began a gradual end to a nationwide lockdown due to the coronavirus disease (COVID-19) outbreak, France, May 18, 2020. REUTERS/Benoit Tessier
HEALTH-CORONAVIRUS/FRANCE-TESTS
RTX7JH8D
May 18, 2020
A staff member takes a blood sample for COVID-19 serological test on a woman at a laboratory in Neuilly-sur-Seine...
Neuilly-Sur-Seine, France
Outbreak of the coronavirus disease (COVID-19) in Paris
A staff member takes a blood sample for COVID-19 serological test on a woman at a laboratory in Neuilly-sur-Seine near Paris after France began a gradual end to a nationwide lockdown due to the coronavirus disease (COVID-19) outbreak, France, May 18, 2020. REUTERS/Benoit Tessier
Sort by
Display
Items per page
Page
of 128